Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation Ruchika Sharma25 May 2025 11:00 AM ISTBerlin: Bayer has announced initiation of a Phase I clinical trial with BAY 3670549, an investigational highly selective G-protein-coupled...
Preoperative Flow Assessment has Limited Benefit in First-Time Isolated CABG: Study Medha Baranwal24 May 2025 9:00 AM ISTSweden: Researchers have found through a large registry study that preoperative physiological flow assessments, such as fractional flow reserve (FFR),...
Popular weight-loss drugs following bariatric surgery may offer additional CV benefits: Study Dr. Kamal Kant Kohli23 May 2025 10:00 PM ISTMedications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events...
MRI breakthrough could revolutionize diagnosis of common heart problem aortic stenosis: Study Dr. Kamal Kant Kohli23 May 2025 9:00 PM ISTUniversity of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than...
Simple test could better predict risk of heart disease, reveals research Dr. Prem Aggarwal23 May 2025 8:45 PM ISTFor almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of cardiovascular disease....
Chronic Conditions Dominate Global Health Burden, GBD 2019 Study Reports Meghna A Singhania23 May 2025 5:10 PM ISTChronic care needs account for the majority of global disease burden-comprising 68% of all disability-adjusted life years (DALYs) and over 86% of...
Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025 Deeksha Bhandari23 May 2025 4:58 PM ISTFirst-of-its-kind head-to-head TAVI trial reinforces the performance and safety of the Next Gen Myval THV series
Age and Blood Pressure Drive Arterial Stiffness Progression in Japanese Adults: New Risk Score Developed Meghna A Singhania23 May 2025 4:26 PM ISTAge, blood pressure, and metabolic risk factors can predict arterial stiffness progression over five years, a recent study has reported.Published in...
Alembic Pharma bags USFDA nod for high BP traetment drug Ruchika Sharma23 May 2025 3:29 PM ISTVadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for Amlodipine...
Senores Pharma boosts heart health portfolio with acquisition of USFDA approved Enalapril Tablets ANDA from Wockhardt Ruchika Sharma23 May 2025 11:00 AM ISTAhmedabad: Senores Pharmaceuticals Limited (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (SPI), has signed ...
Complete Revascularization Offers Long-Term Advantage in STEMI With Multivessel Disease, Study Finds Dr. Prem Aggarwal23 May 2025 8:30 AM ISTDenmark: A decade after undergoing primary treatment, patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery...
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
